Celecoxib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00482 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 50 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 2 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 3 | rheumatoid vasculitis | KG + DL |
| 4 | myosclerosis | KG + DL |
| 5 | hypermobility of coccyx | KG + DL |
| 6 | brachyolmia | KG + DL |
| 7 | rheumatoid nodulosis | KG + DL |
| 8 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | KG + DL |
| 9 | inflammatory spondylopathy | KG + DL |
| 10 | WHIM syndrome | KG + DL |
| 11 | Kummell disease | KG + DL |
| 12 | juvenile chronic polyarthritis | KG + DL |
| 13 | polyarticular juvenile rheumatoid arthritis | KG + DL |
| 14 | vertebral disease | KG + DL |
| 15 | pseudoachondroplasia | KG + DL |
| 16 | brachydactyly-syndactyly syndrome | KG + DL |
| 17 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 18 | leukoplakia | KG + DL |
| 19 | mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency | KG + DL |
| 20 | combined immunodeficiency due to moesin deficiency | KG + DL |
| 21 | psoriasis-related juvenile idiopathic arthritis | KG + DL |
| 22 | hypotrichosis simplex of the scalp | KG + DL |
| 23 | diffuse alopecia areata | KG + DL |
| 24 | gout | KG + DL |
| 25 | congenital hypotrichosis milia | KG + DL |
| 26 | vertebral joint disease | KG + DL |
| 27 | ankylosis (disease) | KG + DL |
| 28 | avascular necrosis of femoral head, primary | KG + DL |
| 29 | transient arthropathy | KG + DL |
| 30 | ganglion or cyst of synovium/tendon/bursa | KG + DL |
| 31 | Behcet syndrome arthropathy | KG + DL |
| 32 | de Quervain disease | KG + DL |
| 33 | shoulder impingement syndrome | KG + DL |
| 34 | articular cartilage disease | KG + DL |
| 35 | tenosynovitis | KG + DL |
| 36 | qualitative platelet defect | KG + DL |
| 37 | fibroma | KG + DL |
| 38 | bursitis | KG + DL |
| 39 | Czech dysplasia, metatarsal type | KG + DL |
| 40 | gingival hypertrophy | KG + DL |
| 41 | spondyloepimetaphyseal dysplasia, Handigodu type | KG + DL |
| 42 | platyspondylic dysplasia, Torrance type | KG + DL |
| 43 | Stickler syndrome, type I, nonsyndromic ocular | KG + DL |
| 44 | spondylometaphyseal dysplasia, Schmidt type | KG + DL |
| 45 | dermatofibrosarcoma protuberans | KG + DL |
| 46 | alopecia | KG + DL |
| 47 | megaepiphyseal dwarfism | KG + DL |
| 48 | mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis | KG + DL |
| 49 | spondyloperipheral dysplasia-short ulna syndrome | KG + DL |
| 50 | infantile systemic hyalinosis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.